(2026). AI-driven de novo design of BRAF inhibitors with enhanced binding affinity and optimized drug-likeness. PeerJ.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"AI-driven De Novo Design of BRAF Inhibitors with Enhanced Binding Affinity and Optimized Drug-likeness."
PeerJ 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"AI-driven De Novo Design of BRAF Inhibitors with Enhanced Binding Affinity and Optimized Drug-likeness."
PeerJ, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.